# Effects of Homocysteine Circulating Levels on Human Spontaneous Fertility and In Vitro Fertilization Outcomes: A Literature Review

**Authors:** Alberto Revelli, Anna Maria Nuzzo, Laura Moretti, Silvana Arduino, Sofia Roero, Roberto Scali, Lorenzo Scali, Gianluca Gennarelli, Francesca Gigliotti, Marlisa Gatto, Alessandro Rolfo

PMC · DOI: 10.3390/nu17203211 · Nutrients · 2025-10-13

## TL;DR

High homocysteine levels affect fertility in both men and women, impacting natural conception and IVF success, but can be managed with supplements.

## Contribution

This review highlights homocysteine's role in reproductive health and its modifiable impact through folate and B-vitamin supplementation.

## Key findings

- High homocysteine in men reduces sperm DNA integrity and testicular blood flow.
- In women, high homocysteine disrupts follicular growth and increases pregnancy risks.
- Folate and B-vitamin supplementation can mitigate homocysteine's negative effects on fertility.

## Abstract

Background: Homocysteine (Hcy) plays a pivotal role in human reproduction, influencing gamete quality, embryo development, implantation, and pregnancy outcomes. It is central to folate and methionine metabolism and supports methylation-dependent epigenetic processes. Hyperhomocysteinemia (HHcy) exerts diverse biological effects and is associated with reproductive impairments in both sexes, affecting both spontaneous fertility and the outcome of assisted reproduction, including In Vitro Fertilization (IVF). Although the mechanisms of HHcy toxicity in reproduction are not fully understood, significant progress has been made in elucidating its effects. The emerging picture is complex, as Hcy and its metabolites impact biomolecules and cellular processes in a tissue- and sex-specific manner. Results: In men, HHcy compromises sperm deoxyribonucleic acid (DNA) integrity, methylation, and testicular microcirculation, reducing fertility potential. In women, HHcy disrupts follicular growth, oocyte competence, embryo quality, and endometrial receptivity, increasing the risk of implantation failure, miscarriage, and pregnancy complications. In assisted reproduction, HHcy and 5,10-methylenetetrahydrofolate reductase (MTHFR) variants may lower oocyte yield and embryo quality, although folate and B-vitamin supplementation can mitigate these effects. Conclusions: These effects largely reflect oxidative, inflammatory, vascular and epigenetic mechanisms, highlighting Hcy as a modifiable factor for improving natural fertility, optimizing IVF outcomes, and supporting healthy offspring development.

## Linked entities

- **Chemicals:** homocysteine (PubChem CID 778), folate (PubChem CID 135405876)

## Full-text entities

- **Genes:** MTHFR (methylenetetrahydrofolate reductase) [NCBI Gene 4524]
- **Diseases:** miscarriage (MESH:D000022), complications (MESH:D008107), toxicity (MESH:D064420), HHcy (MESH:D020138), reproductive impairments (MESH:D060737), implantation failure (MESH:D051437), inflammatory (MESH:D007249)
- **Chemicals:** methionine (MESH:D008715), folate (MESH:D005492), Hcy (MESH:D006710)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12567194/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12567194/full.md

## References

155 references — full list in the complete paper: https://tomesphere.com/paper/PMC12567194/full.md

---
Source: https://tomesphere.com/paper/PMC12567194